FGF23, Frailty, and Falls in SPRINT

Anna Jovanovich1,2, Charles Ginsberg3, Zhiying You2

  • 1VA Eastern Colorado Healthcare System, Aurora, Colorado.

Summary

Fibroblast growth factor 23 (FGF23) is linked to frailty and increased fall risk in individuals with chronic kidney disease (CKD). This study highlights FGF23 as a potential biomarker for adverse outcomes in CKD patients.

Related Concept Videos